NASDAQ:DNDN

Tag: NASDAQ:DNDN

Dendreon Corporation. Non Normal Trade in last session - NASDAQ:DNDN

Posted by tom on February 28th, 2012

Dendreon Corporation (NASDAQ:DNDN) Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. Dendreon Corporation witnessed volume of 38.99 million shares during last trade however it holds an average trading capacity of 10.12 million shares.

Tags:

DNDN, NASDAQ:DNDN, Dendreon

Dendreon Corporation engaged in an Active Trade - NASDAQ:DNDN

Posted by david on February 7th, 2012

Dendreon Corporation (NASDAQ:DNDN) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. Dendreon Corporation witnessed volume of 30.14 million shares during last trade however it holds an average trading capacity of 11.01 million shares.

Tags:

DNDN, NASDAQ:DNDN, Dendreon

Upward Momentum of Dendreon Corporation - NASDAQ:DNDN

Posted by david on January 12th, 2012

Dendreon Corporation (NASDAQ:DNDN) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. Dendreon Corporation witnessed volume of 24.71 million shares during last trade however it holds an average trading capacity of 7.61 million shares.

Tags:

DNDN, NASDAQ:DNDN, Dendreon

Dendreon Corporation recently showed an outstanding Trade - NASDAQ:DNDN

Posted by akki on January 10th, 2012

Dendreon Corporation (NASDAQ:DNDN) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. Dendreon Corporation witnessed volume of 28.54 million shares during last trade however it holds an average trading capacity of 6.30 million shares.

Tags:

DNDN, NASDAQ:DNDN, Dendreon

Dendreon Corporation appeared with Bullish Trend - NASDAQ:DNDN

Posted by akki on January 6th, 2012

Dendreon Corporation (NASDAQ:DNDN) (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. Dendreon Corporation witnessed volume of 46.07 million shares during last trade however it holds an average trading capacity of 4.22 million shares.